Page last updated: 2024-10-26

enoxacin and Colorectal Neoplasms

enoxacin has been researched along with Colorectal Neoplasms in 1 studies

Enoxacin: A broad-spectrum 6-fluoronaphthyridinone antibacterial agent that is structurally related to NALIDIXIC ACID.
enoxacin : A 1,8-naphthyridine derivative that is 1,4-dihydro-1,8-naphthyridine with an ethyl group at the 1 position, a carboxy group at the 3-position, an oxo sustituent at the 4-position, a fluoro substituent at the 5-position and a piperazin-1-yl group at the 7 position. An antibacterial, it is used in the treatment of urinary-tract infections and gonorrhoea.

Colorectal Neoplasms: Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wenzel, M1
Sörgel, F1
Muth, P1
Kraeft, H1

Other Studies

1 other study available for enoxacin and Colorectal Neoplasms

ArticleYear
[Enoxacin concentrations in serum and in the wall of the colon during colorectal surgery].
    Infection, 1989, Volume: 17 Suppl 1

    Topics: Aged; Aged, 80 and over; Colitis; Colon; Colorectal Neoplasms; Enoxacin; Female; Humans; Intestinal

1989